Sharon Lu

1.2k total citations
48 papers, 876 citations indexed

About

Sharon Lu is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sharon Lu has authored 48 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Surgery and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sharon Lu's work include Nausea and vomiting management (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Sharon Lu is often cited by papers focused on Nausea and vomiting management (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Sharon Lu collaborates with scholars based in United States, Spain and United Kingdom. Sharon Lu's co-authors include Amy Rock Wohl, Sameer K. Nath, Brent S. Rose, Loren K. Mell, Jong‐Hyeon Jeong, Gildon Beall, Wilbert Jordan, Denise F. Johnson, Judith S. Currier and Peter R. Kerndt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Sharon Lu

48 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Lu United States	17	362	193	168	130	112	48	876
Bingfeng Han China	13	509 1.4×	213 1.1×	123 0.7×	203 1.6×	349 3.1×	34	1.6k
Andréia Cristina de Melo Brazil	20	583 1.6×	136 0.7×	105 0.6×	136 1.0×	342 3.1×	143	1.3k
T. Reid United States	18	472 1.3×	139 0.7×	163 1.0×	84 0.6×	539 4.8×	53	1.4k
Anne Rigg United Kingdom	13	379 1.0×	60 0.3×	150 0.9×	66 0.5×	209 1.9×	37	971
David J. Hunter United States	14	374 1.0×	163 0.8×	139 0.8×	92 0.7×	349 3.1×	29	1.3k
Jean-Marie Dangou Senegal	13	468 1.3×	292 1.5×	42 0.3×	71 0.5×	100 0.9×	43	1.2k
Taha Koray Şahin Türkiye	18	561 1.5×	126 0.7×	137 0.8×	143 1.1×	200 1.8×	83	1.1k
Shayna L. Showalter United States	18	510 1.4×	93 0.5×	36 0.2×	188 1.4×	122 1.1×	72	1.1k
Jun She China	15	186 0.5×	120 0.6×	154 0.9×	69 0.5×	315 2.8×	26	989
Sophie Papa United Kingdom	23	952 2.6×	138 0.7×	271 1.6×	120 0.9×	281 2.5×	57	1.8k

Countries citing papers authored by Sharon Lu

Since Specialization

Citations

This map shows the geographic impact of Sharon Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Lu more than expected).

Fields of papers citing papers by Sharon Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Lu. The network helps show where Sharon Lu may publish in the future.

Co-authorship network of co-authors of Sharon Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Lu. A scholar is included among the top collaborators of Sharon Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Lu. Sharon Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lu, Sharon, et al.. (2025). Current Status and Future Directions of Ferroptosis Research in Breast Cancer: Bibliometric Analysis. Interactive Journal of Medical Research. 14. e66286–e66286. 2 indexed citations

2.

Lu, Sharon, et al.. (2023). Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis. British Journal of Clinical Pharmacology. 89(7). 2272–2282. 1 indexed citations

3.

Lu, Sharon, Eileen Rakovitch, Breffni Hannon, et al.. (2023). Palliative Care as a Component of High Value and Cost-Saving Care During Hospitalization for Metastatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e602–e603. 1 indexed citations

4.

Ramalingam, Suresh S., Mark M. Awad, Afshin Dowlati, et al.. (2021). JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer. Cancer. 128(1). 65–74. 58 indexed citations

5.

Lu, Sharon, Ronald R. Bowsher, Amy K. Rosen, et al.. (2021). An Integrated Analysis of Dostarlimab Immunogenicity. The AAPS Journal. 23(5). 96–96. 12 indexed citations

6.

Patnaik, Amita, Glen J. Weiss, Drew Rasco, et al.. (2021). Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial. Cancer Chemotherapy and Pharmacology. 89(1). 93–103. 14 indexed citations

7.

Wang, Jing, et al.. (2018). Effects of rolapitant administered orally on the pharmacokinetics of dextromethorphan (CYP2D6), tolbutamide (CYP2C9), omeprazole (CYP2C19), efavirenz (CYP2B6), and repaglinide (CYP2C8) in healthy subjects. Supportive Care in Cancer. 27(3). 819–827. 14 indexed citations

8.

Lu, Sharon, Vikram Kansra, Shefali Agarwal, et al.. (2017). Human mass balance study and metabolite profiling of 14C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer. Investigational New Drugs. 35(6). 751–765. 30 indexed citations

9.

Gillespie, Erin F., Kaveh Zakeri, James D. Murphy, et al.. (2017). Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer. Advances in Radiation Oncology. 2(2). 105–109. 30 indexed citations

10.

Wang, Xiaodong, Zhiyi Zhang, Sujata Arora, et al.. (2017). Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers. The Journal of Clinical Pharmacology. 58(2). 202–211. 14 indexed citations

11.

Lu, Sharon, et al.. (2015). Sequential versus “sandwich” sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma. Gynecologic Oncology. 137(1). 28–33. 22 indexed citations

12.

Hughes, Robert, Todd M. Maddux, D. Joseph Rogier, et al.. (2011). Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent region. Bioorganic & Medicinal Chemistry Letters. 21(21). 6348–6352. 12 indexed citations

13.

Lu, Sharon, et al.. (2011). Evaluation of two intracavitary high-dose-rate brachytherapy devices for irradiating additional and irregularly shaped volumes of breast tissue. Medical dosimetry. 37(1). 9–14. 4 indexed citations

14.

Tykodi, Scott S., Nobuharu Fujii, Nathalie Vigneron, et al.. (2008). C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients. Clinical Cancer Research. 14(16). 5260–5269. 43 indexed citations

15.

Deapen, Dennis, Myles Cockburn, Rich Pinder, Sharon Lu, & Amy Rock Wohl. (2007). Population-Based Linkage of AIDS and Cancer Registries. American Journal of Preventive Medicine. 33(2). 134–136. 6 indexed citations

16.

Wohl, Amy Rock, Sharon Lu, Andrea Kovacs, et al.. (2003). Risk of Opportunistic Infection in the HAART Era Among HIV-Infected Latinos Born in the United States Compared to Latinos Born in Mexico and Central America. AIDS Patient Care and STDs. 17(6). 267–275. 12 indexed citations

17.

Wohl, Amy Rock, et al.. (2001). Comparison of AIDS Progression and Survival in Persons with Pulmonary versus Extrapulmonary Tuberculosis in Los Angeles. AIDS Patient Care and STDs. 15(9). 463–471. 8 indexed citations

18.

Wohl, Amy Rock, Denise F. Johnson, Wilbert Jordan, et al.. (2000). High-Risk Behaviors During Incarceration in African-American Men Treated for HIV at Three Los Angeles Public Medical Centers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(4). 386–392. 59 indexed citations

19.

Wohl, Amy Rock, Denise F. Johnson, Wilbert Jordan, et al.. (2000). High-Risk Behaviors During Incarceration in African-American Men Treated for HIV at Three Los Angeles Public Medical Centers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(4). 386–392. 34 indexed citations

20.

Wohl, Amy Rock, et al.. (1998). Sociodemographic and Behavioral Characteristics of African-American Women With HIV and AIDS in Los Angeles County, 1990-1997. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(4). 413–420. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact